RxTEC: the new shape of track-and-trace systems?
Newly announced Pharmaceutical Distribution Safety Alliance is for product serialization, but against item-level tracking
Cegedim passes 8-million mark with validated, global identification of healthcare providers
Now covering 69 countries, Cegedim provides a resource for global biopharma companies to sell--globally
Bringing room-temperature pharma shipping under the 'CRT' umbrella
'Controlled room temperature' (CRT) shipping is being transformed from standard shipping processes to engineered, compliance-ready processes and materials
AmerisourceBergen will acquire World Courier for its clinical and specialty logistics services
While UPS and and FedEx apparently passed on the acquisition, ABC will be expanding its footprint in clinical logistics, and its commercial distribution services globally
Cegedim passes 8-million mark with valifdated, global identification of healthcare providers
Biosimilars take a big step toward the marketplace
FDA's draft documents on biosimilar regulation move the prospect one step closer
Adding rigor to the adverse event reporting process
As FDA makes progress on an active surveillance system, drug manufacturers and third-party drug safety vendors navigate their own set of challenges
NEHI: Medication adherence needs better coordination among stakeholders
Pharma industry serves best as underwriter of healthcare providers' efforts
Supply chain issues for 2012
Tompkins International's annual preview of key pharma supply chain issues
Cancer care in the US -- looking back, looking forward
Begin thinking of your business as a 'disease' company vs. a 'drug' company
A conversation with Chris Smith, H. D. Smith
Pharmaceutical Commerce sat down with Chris Smith, president and COO; here's what he had to say.
USP ventures into standards for supply chain integrity
National organization proposes a draft standard; will hold workship in May
Inmar signs up Cardinal Health for reverse logistics services; now handles all of the Big Three wholesalers
Analytics based on returns data can be a marketing tool for manufacturers
Novartis shuffles OTC management, wants
Former OTC head, known for her marketing expertise, is out the door
Cardinal loses this round of litigation with DEA over Lakeland DC suspension
Federal judge lifts temporary restraining order against DEA; action now moves to DEA administrative judge
McKesson deepens ownership in Canadian retail pharmacy
Buys marketing rights to networks of independent pharmacies for C$920 million
Now, analyze packaging materials before final formulation is complete
Bilcare Research brings multiphase stability and shelf-life testing to drug developers as a step to choosing the right blister-card materials
Apothecary Shops continues fast growth with distribution agreements for specialty pharmaceuticals
Exclusive distribution of Mobius Therapeutics' Mitosol (mitomycin) is the latest win
Veeva adds sample and promotion ordering to its cloud-based CRM
Announces more contract wins; integration with other software platforms in sales force automation
Spring conference of HPCLC is set
Program adds a one-day seminar on business continuity planning
Channel data management: Diving deep in the channel data mine
While 'data mining' is the catchphrase of the moment for business analytics, some pharma companies are finding value in mining their channel data assets
Manufacturers are reviving their serialization plans
The pioneering firms that installed serialization and track-and-trace systems are being joined by a fast follower crowd, but an industry-wide commitment is still in the future
Regulatory snares affect Envirotainer, OHL Solutions
OHL pays a $1-million fine for misreporting TSA inspections; Envirotainer is bollixed by FAA
Counterfeit Avastin scandal widens; injectables emerge as a new focus of criminal mischief
Health authorities in the US and Europe are chasing down counterfeit sources
Online monitoring of pharmaceutical-distribution websites can identify counterfeit or diverted product
Avastin scandal throws a spotlight on trade-activity monitoring
On-dose product authentication will get a commercial tryout
NanoGuardian’s NanoEncryption technology wins a multiyear agreement with top-10 manufacturer
Counterfeit Avastin shows up in US cancer clinics
FDA believes that the fakes were obtained from an offshore distributor, supplying another distributor in Tennessee; Genentech confirms fakes contain no active ingredient
Model N acquires LeapFrogRx, proposes “enterprise revenue intelligence” as a commercial-operations practice
Acquisition continues growth of data mining into product marketing and pricing
Cardinal's ongoing tussle with DEA over controlled-substances distribution
Federal judge asks DEA for show cause information; DEA claims millions of suspicious orders
